References
  1. Martin WJ (1994) Stealth viruses as neuropathogens. College of American Pathologist’s Publication. CAP Today 8: 67-70.
  2. Martin WJ, Zeng LC, Ahmed K, Roy M (1994) Cytomegalovirus-related sequences in an atypical cytopathic virus repeatedly isolated from a patient with the chronic fatigue syndrome. Am. J. Path.  145: 441-452.
  3. Martin WJ, Ahmed KN, Zeng LC, Olsen JC, Seward JG, Seehrai JS (1995) African green monkey origin of the atypical cytopathic ’stealth virus’ isolated from a patient with chronic fatigue syndrome. Clin. Diagn. Virol. 4(1):93-103.
  4. Martin WJ (1996) Severe stealth virus encephalopathy following chronic fatigue syndrome-like illness: Clinical and histopathological features. Pathobiology  64:1-8.
  5. Martin WJ (1999) Stealth adaptation of an African green monkey simian cytomegalovirus. Exp. Mol. Pathol. 66(1): 3-7
  6. Martin WJ (2014) Stealth adaptation of viruses: review and updated molecular analysis on a stealth adapted African green monkey simian cytomegalovirus (SCMV). J. Hum. Virol. Retrovirology 1(4): 104‒116.
  7. Martin WJ (2014) Stealth Adapted Viruses; Alternative Cellular Energy (ACE) & KELEA Activated Water. Author House, Bloomington IN p321.
  8. Martin WJ (1998) Cellular sequences in stealth viruses.Pathobiology 66(2): 53-8.
  9. Martin WJ (1999) Bacteria-related sequences in a simian cytomegalovirus-derived stealth virus culture. Exp. Mol. Pathol. 66(1): 8-14.
  10. Martin WJ (2019) Renegade cellular and bacterial genetic sequences in stealth adapted viruses. J Human Virol & Retrovirology 7(2): 26-40.
  11. Martin WJ (2020) Viruses disguised as self and/or as bacteria.Microbiology and Infectious Diseases 4(1): 1-5.
  12. Martin WJ (2020) Infectious, rhesus monkey‐derived cellular DNA sequences in certain stealth adapted viruses. The FASEB Journ al 34(S1): Pub. 20 April 2020.
  13. Martin WJ (2020) Virus transmission to humans of genetically unstable rhesus monkey cellular sequences: A possible forerunner of complex human illnesses. J. Hum. Virol. Retroviology 8(3): 74‒82.
  14. Martin WJ (2022) Renegade cellular genetic sequences in stealth adapted viruses: introducing a new era of virology. J. Hum. Viro.l Retrovirology 9(1): 24‒29.
  15. Martin WJ (2022) Renegade bacterial genetic sequences in a stealth adapted virus: Biological and diagnostic implications.bioRxiv  10.11.511846.
  16. Sabin AB (1959) Present position of immunization against poliomyelitis with live virus vaccines. Br. Med. J. 1(5123): 663-80.
  17. Valensin PE, Cioni C, Fanelli M (1967) Adventitious agents in African green monkey kidney tissue cultures used for the production of live attenuated poliomyelitis vaccine. Prog. Immunobiol. Stand . 3: 49-52.
  18. Boot R, Kruijt BC, van Steenis G, van Wezel AL (1981) Breeding of Macaca fascicularis for poliovaccine production. Dev. Biol. Stand. 47: 15-8.
  19. Sierra-Honigmann AM, Krause PR (2002) Live oral poliovirus vaccines and simian cytomegalovirus. Biologicals 30(3): 167-74.
  20. Baylis SA, Shah N, Jenkins A, Berry NJ, Minor PD (2003) Simian cytomegalovirus and contamination of oral poliovirus vaccines.Biologicals 31(1): 63-73.
  21. Martin WJ (2021) Stealth adapted viruses can be traced to the inadvertent use of cytomegalovirus-infected monkeys to produce polio vaccines. Cohesive J. Microbiol. Infect. Dis. 5(1). CJMI. 000604.
  22. Mohebbi A, Tahamtan A, Eskandarian S, Askari FS, Shafaei M, Lorestani N (2018) Viruses and long non-coding RNAs: implicating an evolutionary conserved region. Virus Disease 29(4): 478-485.
  23. Jia Chen, Jiahao Lin, Yongfei Hu, Meijun Ye, Linhui Yao et al (2023) RNADisease v4.0: an updated resource of RNA-associated diseases, providing RNA-disease analysis, enrichment and prediction, Nucleic Acids Research 51: 1397-1404.
  24. Bridges MC, Daulagala AC, Kourtidis A (2021) LNCcation: lncRNA localization and function. J. Cell. Biol. 220(2): e202009045.
  25. McDonel P, Guttman M (2019) Approaches for understanding the mechanisms of long noncoding RNA regulation of gene expression.Cold Spring Harb. Perspect. Biol. 11(12): a032151.
  26. Marchese FP, Raimondi I, Huarte M (2017) The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 2017 18(1): 206.
  27. Zhang Y, Tao Y, Liao Q (2018) Long noncoding RNA: a crosslink in biological regulatory network. Brief Bioinform. 19(5): 930-945.
  28. Bai Y, Dai X, Harrison AP, Chen M (2015) RNA regulatory networks in animals and plants: a long noncoding RNA perspective. Brief Funct. Genomics 14(2): 91-101.
  29. Martin WJ (1997) Detection of RNA sequences in cultures of a stealth virus isolated from the cerebrospinal fluid of a health care worker with chronic fatigue syndrome. Case report. Pathobiology65(1):57-60.
  30. Martin WJ (2020) Chronic fatigue syndrome (CFS): An imprecisely defined infectious disease caused by stealth adapted viruses. J. Infect. Dis. Epidemiology 6: 106.
  31. Martin WJ (1995) Stealth virus isolated from an autistic child.J. Autism Dev. Disord. 25(2): 223-4.
  32. Durie BG, Collins RA, Martin WJ (2000) Positive stealth virus cultures in myeloma patients: A possible explanation for neuropsychiatric co-morbidity. Blood 96: 29.
  33. Martin WJ (2015) Stealth adapted viruses: A bridge between molecular virology and clinical psychiatry. Open J. Psychiatry  5: 311-319.
  34. Martin WJ (1996) Stealth viral encephalopathy: Report of a fatal case complicated by cerebral vasculitis. Pathobiology 64: 59-63.
  35. Martin WJ (1996) Simian cytomegalovirus-related stealth virus isolated from the cerebrospinal fluid of a patient with bipolar psychosis and acute encephalopathy. Pathobiology 64(2): 64-6.
  36. Martin WJ (2020) Complex multi-system illnesses occurring within a family: Presumptive evidence for an infectious disease process.J. Neuro.l Stroke 10(1): 34‒36.
  37. Hyde B (1992) The Clinical and Scientific Basis of Myalgic Encephalomyelitis - Chronic Fatigue Syndrome. Nightingale Research Foundation Press , Ottawa, Canada.
  38. Glass RT (2000) Abnormal signs found in animals of myalgic encephalomyelitis/chronic fatigue syndrome patients. J. Chronic Fatigue Syndrome 6: 73-81.
  39. Glass RT (2000) The human/animal interaction in myalgic encephalomyelitis/chronic fatigue syndrome. J. Chronic Fatigue Syndrome 6: 65-72.
  40. Martin WJ, Glass RT (1995) Acute encephalopathy induced in cats with a stealth virus isolated from a patient with chronic fatigue syndrome.Pathobiology 63: 115-118.
  41. Martin WJ (2017) The many biological functions of the alternative cellular energy (ACE) pathway. International J. Complement. Alt. Medicine 7(5): 00237
  42. Martin WJ (2021) Enhancing the alternative cellular energy (ACE) pathway with KELEA activated water as therapy for infectious diseases.Infect. Disord. Drug Targets 21(3): 314-319.
  43. Martin WJ (2023) Reinvigorating the Body’s Healing and Regenerative Capacities by Enhancing the Alternative Cellular Energy (ACE) Pathway with KELEA (Kinetic Energy Limiting Electrostatic Attraction). Submitted